- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05716789
Cardiopulmonary Resuscitation in Cases of Sudden Cardiac Arrest
The Success Rate of Cardiopulmonary Resuscitation in Sudden Cardiac Arrest
Study Overview
Detailed Description
Cardiac arrest is a medical emergency that requires immediate cardiopulmonary resuscitation (CPR). Return of spontaneous circulation (ROSC) is a core outcome element of cardiopulmonary resuscitation (CPR) both in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest and has been considered a standard in the evaluation of successful resuscitation.
ROSC was defined as a clinical assessment that shows signs of life comprising of a palpable pulse for at least 20 minutes or generating a blood pressure, the duration of ROSC is key element not only to the efficacy of the chain of survival but also to assess the success of resuscitation in emergency medical services (EMSs).
Worldwide CPR outcomes vary due to differences in the circumstances of cardiac arrest, availability of equipment, and performance of the CPR team. The influencing factors of CPR outcome at the emergency room (ER) are patient characteristics, early detection, immediate CPR, initial shockable rhythm, duration of CPR of less than 10 minutes and advanced cardiac life support.
In Egypt, There has been scarce studies regarding CPR and studies that measure the success rate of CPR and factors determining its success. This study aims to assess the success rate of CPR in Emergency room and factors predicting successful CPR on adults.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Alhusein Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Resuscitated at the ER in Al Hussein University Hospital.
- Patients Have experienced cardiac arrest.
Exclusion Criteria:
- Patient arresting and receiving CPR inside hospital's other departments.
- Signs of sure death.
- Patient with Multiple Organ Failure Syndrome (M.O.F syndrome
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CPR asseement
determine the success rate of CPR in Emergency room and factors predicting successful CPR
|
CPR in cardiac arrest patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CPR Success Rate
Time Frame: From base line to 20 minutes.
|
The rate of CPR defined by the Return of spontaneous circulation(ROSC) rate, Survival to hospital admission rate and survival to hospital discharge rate.
|
From base line to 20 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
predictors of Return of spontaneous circulation(ROSC)
Time Frame: from base line to 8 hoiurs
|
ROSC was defined as a clinical assessment that shows signs of life comprising of a palpable pulse for at least 20 minutes or generating a blood pressure, the duration of ROSC is key element not only to the efficacy of the chain of survival but also to assess the success of resuscitation in emergency medical services
|
from base line to 8 hoiurs
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ahmed Mohamed Abdelgaleel, Professor, Al-Azhar University, Faculty of medicine for boys
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Osama Hamdy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.